• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Viasys Healthcare

Viasys Healthcare

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Mainstay Medical Publishes 2016 Full Year Results and Business Update

    Mainstay Medical Publishes 2016 Full Year Results and Business Update

  2. What Advisors Don’t Know About Variable Annuities: Market Conditions and VAs

    In part four of our series, we look at how market conditions affect variable annuities. VAs may appear, on paper, to be a win-win, but the reality is more nuanced.

  3. MetLife VAs flounder as Fidelity halts sales

    The insurer's variable annuities dipped 39% year-over-year in the second quarter, offering a glimpse into the power of big distributors like Fidelity.

  4. Chugai's Anti-IL-31 Receptor A Humanized Monoclonal Antibody "nemolizumab (CIM331)" Global Phase II Study Data Published in The New England Journal of Medicine Online

    Chugai's Anti-IL-31 Receptor A Humanized Monoclonal Antibody "nemolizumab (CIM331)" Global Phase II Study Data Published in The New England Journal of Medicine Online

  5. Fixed indexed annuity sales gaining on VAs : Cerulli

    Fixed indexed annuity sales are steadily gaining on those of variable annuities, thanks in large part to continued low interest rates.

  6. Jackson National to offer DoubleLine smart beta fund in VAs

    Smart-beta strategies got their latest seal of approval in the form of a $100 million mandate from variable annuity giant Jackson National, which has added the DoubleLine Shiller Enhanced CAPE Fund to its menu of VA investment options.

  7. Time for More ETF-Based VAs

    ETFs could help solve the high costs that dog variable annuities.

  8. How insurers are losing when it comes to variable annuities

    Tight restrictions are placed on investment options in VAs with guaranteed income to reduce their risk. Returns have lagged as a result, frustrating advisers and investors.

  9. Finra targets variable annuities as 'sweet spot' of scrutiny

    Following record MetLife fine, regulator says VAs are now at the core of their focus: complex products marketed to seniors.

  10. What Advisors Don’t Know About Variable Annuities: How VAs Fit Into a Client’s Portfolio

    Properly assessing the viability of a variable annuity for a particular client entails considerably more than just adding it alongside a standard model portfolio.

123

©2017 Morningstar Advisor. All right reserved.